Percutaneous Radiofrequency Treatment of the Cervical Facet joints compared with Cervical Medial Branch block of the Facet Joints for Patients with Chronic Degenerative Neck pain : A Prospective Randomized Clinical Study

Percutaneous Radiofrequency Treatment of the Cervical Facet joints compared with Cervical Medial Branch block of the Facet Joints for Patients with Chronic Degenerative Neck pain : A Prospective Randomized Clinical Study - RFD of the cervical facet joints versus Cervical Medial Branch block.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON37554

Enrollment

Registered

2012-09-07

Start date

2013-02-07

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cervical facet degeneration facet arthrosis

Interventions

Patients with at least 3 months of neck pain without radiation to the arm will be randomized in 2 groups. The first group (RFD group) will receive a RF treatment adjacent to the medial branch inner

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1) 1) Patient*s age > 25 year 2) Signs of degeneration on lateral X-ray 3) Cervical facets to be treated between C2 and C7 4) Pain for at least 3 months and conservative treatment prior to referral to the painclinic; medication (paracetamol, NSAID*s) and/or physical therapy 5) Neck pain NRS score * 5

Exclusion criteria

Exclusion criteria: 1) Radiation beyond the shoulder/radiculair pain 2) Shoulder pain/pathology 3) The complaints are directly related to traumatic event e.g. Whiplash (WAD) 4) Patient is pregnant, or pregnancy is suspected 5) Patient has a cardiac pacemaker, automatic defibrillator or any leads in the neck area 6) Allergy to contrast media or drugs to be used in the procedure 7) History of anterior fusion at the cervical level to be treated 8) Patient is simultaneously participating in another device or drug study related to cervical pain. 9) Patient has a spinal fracture, tumor or infection. 10) Patient has a central cord lesion in the cervical spine 11) Neurologic deficit 12) Evidence of disc herniation (extruded, sequestered on MRI imaging)

Design outcomes

Primary

Measure	Time frame
The primary research question is to evaluate the extent of pain reduction induced by RF treatment (RFD group) compared with the control group. Following evaluation tools are used : Numeric Rating Scale, Global Perceived Effect on Likert Scale.	—

Secondary

Measure	Time frame
Consumption of pain medication (MQS), Patient Specific Functional Scale, Quality of life scale (RAND 36), Hospital Anxiety and Depression scale (HADS), and Neck Disabilty Index (Dutch version).	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)